Conference abstract
Identification and characterisation of cyclic peptide inhibitors of Ras/p110α and Ras/Raf protein complexes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Ras proteins belong to the GTPase superfamily of proteins; they consist of HRas, NRas and KRas. Ras is involved in various cellular functions cell growth, proliferation, differentiation and activation. Ras proteins behave as molecular switches, and their activity is GTP dependent. Ras-GTP promotes effector binding and activates downstream signalling such as PI3K and Raf pathways. Oncogenic Ras mutations have been found almost 20% of cancers, with KRas being the most highly mutated. These oncogenic mutations prevent the hydrolysis of GTP to GDP resulting in a constant active state of Ras that persistently activates downstream signalling. There have been many efforts to develop inhibitors that interrupt interaction of oncogenic Ras to effector kinases such as PI3K and Raf in order to block their constant activated pathways. These inhibitors however have limited success due to either their weak binding affinity for Ras, or the lack of specificity to Ras mutants. Here, in collaboration with Ali Tavassoli’s lab in Southampton University, we are applying a new approach for discovering inhibitors of Ras mutants. This approach combines two methodologies: The “split-intein cyclisation of peptides and proteins” (SICLOPPS), for producing random cyclic peptides in vivo; and a bacterial reverse two-hybrid system (RTHS), that is used to screen for successful inhibitors. SICLOPPS has the capacity to produce millions of random cyclic peptides, which significantly increases the chances of finding suitable inhibitors, to interrupt protein complexes. At the same time RTHS provides a time efficient and effective technique to screen such a high number of peptides.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Mohamed Ismail”
- BylineArticles whose byline prints “Julian Downward”
